Paris hospitals group, AP-HP, and Biocitech sign cooperation agreement
Partnership aims to speed development of early stage healthcare companies and increase opportunities for those with innovative projects from AP-HP or Biocitech
Advertisement
Biocitech and AP-HP announced that they have signed a cooperation agreement. The agreement was signed by Mireille Faugere, managing director of AP-HP and Jean-Francois Boussard, Biocitech president, at the ninth annual APinnov technology transfer conference in Paris.
Together, the two partners intend to accelerate the creation and scientific development of early-stage life sciences enterprises. Those with projects to propose from AP-HP will be able to use premises at Biocitech, near central Paris, on favorable terms while Biocitech residents will have special access to technological innovations originating in AP-HP. Agreements will cover areas such as technology transfer, co-development or clinical development.
There will be a joint development and oversight committee with representatives from OTTLIV, the technology transfer arm of AP-HP, and from Biocitech. They will be responsible for ensuring the smooth running of joint actions. The committee will take decisions on companies moving into Biocitech with technology originating from AP-HP, on Biocitech residents wanting to access AP-HOP technology and on requests from Biocitech residents wishing to have their medicines evaluated in clinical trials at AP-HP.
Other news from the department business & finance
Most read news
More news from our other portals
Last viewed contents
Pimp my Spec: Upgrade for Magnetic Resonance Methods with a 1,000-fold Amplifier - Atomistically accurate description of proteins at native concentrations can help to better understand the process of cell proliferation to tumour growth
Closure of Astellas CNS research in Edinburgh
Antibody discovered that blocks almost all known HIV variants in neutralization assays - The discovery potentially opens up new perspectives for the prevention and treatment of HIV infections
New method for measuring luminescence lifetime offers breakthrough in scientific imaging - Accelerating the pace of discovery in science and industry
Decreasing biodiversity may promote spread of viruses - New insight into the dynamics of infectious disease
Mysthera Therapeutics Launches to Develop First-in-Class Autoimmune Disease Therapies - Seed Capital from Forty51 Ventures to Advance Pipeline of Pan-PIM Kinase Inhibitors
3D-printed pills with desired drug release – a step upwards in medication - Funny looking pills are not a design gimmick, they can release medication in a desired time regime!
Coronavirus SARS-CoV-2 spreads more indoors at low humidity - Indian-German research team recommends at least 40 percent humidity in public buildings
Chemische Fabrik Dr. Weigert GmbH & Co. KG - Hamburg, Germany
KNAUER now officially a place of the future
